Maryna Rubach

Statistics

Publications

Citations

238

H-Index

Active since

2004

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Maryna Rubach is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and cytokine biomarkers in cancer.

ORCID

Publications per year

2004–2022

Publications

Increased cancer risk of heterozygotes with <i>NBS1</i> germline mutations in poland

Jan Steffen, Raymonda Varon, Maria Mosor et al. · International Journal of Cancer · 2004 · 127 citations

Life Sciences, Genetics, Molecular Genetics +17

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

Matti Aapro, Zoe Caprariu, Petio Chilingirov et al. · European Journal of Cancer · 2022 · 40 citations · Full text

Medicine, Oncology, Pharmacology +14

Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients

Janina Kamińska, Beata Kotowicz, M Kowalska et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2006 · 27 citations

Medicine, Endocrinology, Oncology +9

Management of extravasation of antineoplastic agents

Maryna Rubach · Oncology in Clinical Practice · 2018 · 24 citations · Full text

Medicine, Oncology, Pharmacology +9

Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer

Małgorzata Fuksiewicz, M Kowalska, Beata Kotowicz et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2010 · 20 citations

Medicine, Immunology, Oncology +15

1–5 of 5